Download

Mobile

Desktop

Download now

View more versions

About us

English
中文繁體
中文简体

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
- Topics
  
  Discuss hot topics with like-minded traders
Learn
Investing
- Investment Choices
  
  Explore investment products
  Cash Sweep
  
  Stocks
  
  Fractional Shares
  
  ETFs
  
  Options
  
  Margin Trade
- Features
  
  See our powerful trading features in action
  Charts
  
  Stock Analysis
  
  Level 2 Data
  
  Nasdaq Market Depth
- Pricing
  
  Transparent fees, no account minimums

Open Account

Financial services in the moomoo app are provided by Moomoo Financial Inc. You will be redirected to Moomoo Financial Inc's web domain, where the account application pages are hosted.

Account Info

Log Out

English

Back

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
Learn
Investing
- Investment Choices
  - Cash Sweep
  - Stocks
  - Fractional Shares
  - ETFs
  - Options
  - Margin Trade
- Features
- Pricing
  
  Transparent fees, no account minimums

English
中文繁體
中文简体

Dark
Light

Download

Back to the Top

康哲藥業：自願性及業務進展公告聯營公司新加坡生產工廠及CDMO合作事項

CMS: Voluntary and Business Update Announcement The Singapore Manufacturing Plant Matter and the CDMO Collaboration of an Associate

香港交易所 · Dec 29, 2023 04:59

CMS +0.28%

Summary by Moomoo AI

康哲药业（CMS）於2023年12月27日宣布，其新加坡聯營公司PharmaGend Global Medical Services Pte. Ltd.（PharmaGend）與PERPETUAL (ASIA) LIMITED簽訂租賃協議，租用位於新加坡大士的廠房，將用於開展藥品製劑、精加工和包裝業務。12月29日，PharmaGend完成購買Strides Pharma Global Pte. Ltd.（Strides Pharma）的特定生產機器和設備，並與其簽署特定合同定制生產（CMO）協議及服務協議，標誌著新加坡生產工廠事項的完成。此外，CMS Medical Venture、康聯達、康龍化成及君聯基金於2023年10月20日同意將Rxilient Biohub之註冊資本由200,000美元增加至30,000,000美元，並於12月15日完成增資事項，使得Rxilient Biohub成為CMS的聯營公司。12月20日，Rxilient Biohub更名為PharmaGend。新加坡生產工廠及CDMO合作事項將優化CMS集團海外供應鏈和生產能力，提高供貨穩定性，並有助於與全球合作夥伴開展產品合作。CMS集團將透過此次合作，在東南亞建立製劑CDMO業務，加快業務發展，並構建全球製藥企業在東南亞的「橋頭堡」。

Conge Pharmaceuticals (CMS) announced on 27 December 2023 that its Singapore joint venture PharmaGend Global Medical Services Pte. PharmaGend Ltd. (PharmaGend) has entered into a lease agreement with PERPETUAL (ASIA) LIMITED for the lease of a factory located in Singapore, which will be used for pharmaceutical preparation, refining and packaging business. On December 29, PharmaGend completed the acquisition of Strides Pharma Global Pte. Strides Pharma Ltd.'s specific production of machinery and equipment, and the signing of a specific contract custom manufacturing (CMO) agreement and service agreement with it, marks the completion of the Singapore manufacturing plant. In addition, CMS Medical Venture, Concord, Congolese and Junlian Funds agreed on October 20, 2023 to increase the registered capital of Rxilient Biohub from $200,000 to $30,000,000 and completed the capital increase on December 15, making Rxilient Biohub a joint venture of CMS. On December 20, Rxilient Biohub was renamed PharmaGend. The Singapore factory and CDMO collaboration will optimise CMS Group's overseas supply chain and production capabilities, improve supply stability and help develop product partnerships with global partners. Through this partnership, CMS Group will establish a pharmaceutical CDMO business in Southeast Asia, accelerate business development, and build a global pharmaceutical enterprise in Southeast Asia.

Helpful

Not Helpful

This announcement is a separate document:

Doc 1 View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

Risk Disclaimer

This page is machine-translated. Moomoo tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

The information summarized by Moomoo AI is generated automatically by a third-party artificial intelligence (AI) model based on the news content. It does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliated companies. Due to implementation limitations and technological capabilities, the AI-generated information quality may vary. You agree that any action you take upon the information on this page is at your own risk. You further agree that MTI and its affiliated companies shall not be held liable for any losses or damages incurred as a result of your use of the above information.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.

In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).

In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.

In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our website https://www.moomoo.com/au.

In Canada, order-execution only services available through the moomoo app are provided by Moomoo Financial Canada Inc., regulated by the Canadian Investment Regulatory Organization (CIRO).

In Malaysia, investment products and services available through the moomoo app are offered through Moomoo Securities Malaysia Sdn. Bhd. ("Moomoo MY")regulated by the Securities Commission of Malaysia (SC). Moomoo Securities Malaysia Sdn. Bhd. is a Capital Markets Services Licence (License No. eCMSL/A0397/2024) holder. This advertisement has not been reviewed by the SC.

Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc., and Moomoo Securities Malaysia Sdn. Bhd. are affiliated companies.

Got it

Risk Disclaimer

Got it

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

About moomoo

Terms & Conditions

Licensed Entities*

Your Privacy Choices

Careers / Contact:

hr@us.moomoo.com

The moomoo app is an online trading platform offered by Moomoo Technologies Inc. Securities, brokerage products and related services available through the moomoo app are offered by including but not limited to the following brokerage firms: Moomoo Financial Inc. regulated by the U.S. Securities and Exchange Commission (SEC), Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS), Futu Securities International (Hong Kong) Limited regulated by the Securities and Futures Commission of Hong Kong (SFC), Moomoo Financial Canada Inc. regulated by the Canadian Investment Regulatory Organization (CIRO) and Futu Securities (Australia) Ltd regulated by the Australian Securities and Investments Commission (ASIC).

For further information about Moomoo Financial Inc., please visit Financial Industry Regulatory Authority (FINRA)’s BrokerCheck. Brokerage accounts with Moomoo Financial Inc. are protected by the Securities Investor Protection Corporation (SIPC). Moomoo Financial Inc. is a member of Securities Investor Protection Corporation (SIPC), which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). It is important to understand that SIPC protects customer accounts against losses caused by the financial failure of the broker-dealer, but not against an increase or decrease in the market value of securities in customers' accounts. SIPC does not protect against market risk, which is the risk inherent in a fluctuating market. For further information about SIPC coverage for accounts with Moomoo Financial Inc., see www.sipc.org or request an explanatory brochure from Moomoo Financial Inc.

Options trading entails significant risk and is not appropriate for all customers. It is important that investors read Characteristics and Risks of Standardized Options before engaging in any options trading strategies. Options transactions are often complex and may involve the potential of losing the entire investment in a relatively short period of time. Certain complex options strategies carry additional risk, including the potential for losses that may exceed the original investment amount. Supporting documentation for any claims, if applicable, will be furnished upon request.

Investments in stocks, options, ETFs and other instruments are subject to risks, including possible loss of the amount invested. The value of investments may fluctuate and as a result, clients may lose the value of their investment. Past performance should not be viewed as an indicator of future results.

Margin trading involves interest charges and heightened risks, including the potential to lose more than invested funds or the need to deposit additional collateral. Before trading on margin, customers are advised to determine whether this type of trading is appropriate for them in light of their respective investment objective, experience, risk tolerance and financial situation.

Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin brokerage accounts of U.S. residents that trade U.S. listed securities via mobile devices or Web. Relevant SEC & FINRA fees may apply. For details, please see Commission and Fees.

All types of investments are risky and investors may suffer losses. Past performance of investment products does not guarantee future results. Electronic trading also poses risks to investors. The responsiveness of the trading system may vary due to market conditions, system performance, and other factors. Account access and trade execution may be affected by factors such as market volatility.

No content on the website shall be considered as a recommendation or solicitation for the purchase or sale of securities, futures, or other financial products. All information and data on the website are for reference only and no historical data shall be considered as the basis for predicting future trends.

Information contained on this website is general in nature and has been prepared without any consideration of customers’ investment objectives, financial situations or needs. Customers should consider the appropriateness of the information having regard to their personal circumstances before making any investment decisions.

Investment products are not insured by the Federal Deposit Insurance Corporation (FDIC) or guaranteed by a bank, and may decline in value.

The services and products offered on the website are subject to applicable laws and regulations, as well as relevant service terms and policies. The services and products are not available to all customers or in all geographic areas or in any jurisdiction where it is unlawful for us to offer such services and products.

康哲藥業：自願性及業務進展公告 聯營公司新加坡生產工廠及CDMO合作事項

CMS: Voluntary and Business Update Announcement The Singapore Manufacturing Plant Matter and the CDMO Collaboration of an Associate

Risk Disclaimer

Statement

康哲藥業：自願性及業務進展公告聯營公司新加坡生產工廠及CDMO合作事項